Oncology devices are a wide range of medical devices used in the treatment of cancer. Oncology devices are in-vitro diagnosis and combination device products used in screening, diagnosing, treating, and monitoring premalignant and malignant conditions in patients. Diagnosing cancer is done through a variety of tests, including a physical examination, imaging scans, laboratory tests, and a biopsy of the cells in question. Each of these tests provides valuable information that helps doctors make an accurate diagnosis and determine the best treatment options for their patients. X-rays, a CT (Computed Tomography) scan, an MRI (Magnetic Resonance Imaging), and other types of imaging scans are diagnostic tools that oncology doctors can use to assess the stage of cancer. These imaging scans may use high-energy radiation waves, electromagnetic waves, or a magnetic field to create pictures of the internal organs and tissues. Oncology devices and diagnostics include a range of medical devices that assist patients and providers in screening, diagnosing, treating, and monitoring premalignant and malignant conditions. Oncology devices are used in a variety of settings, including hospitals, clinics, and doctor’s offices. Oncology devices includes radiation therapy device which are used deliver radiation to cancer cells. Radiation therapy can be used to kill cancer cells, to shrink tumors, or to relieve pain. Radiation therapy devices include linear accelerators, brachytherapy machines, and gamma knives. Moreover, the increasing number of people suffering from cancer is driving demand for oncology devices. This, in turn is expected to drive the market growth during the forecast period.
Market Dynamics
Key companies operating in the market are focusing on product launches and obtaining approvals from regulatory agencies, which is expected to facilitate growth of the Latin America oncology devices market during the forecast period. Moreover, government regulatory bodies are focused on enhancing digital healthcare and approving new products for the treatment of cancer. For instance, in March 2020, MEDX HEALTH CORP., a medical device and software company, received regulatory approval from ANVISA to market and sell its SIAscopy on DermSecure skin assessment platform in Brazil. SIAscopy is an imaging technology and a solution for early detection of skin cancer.
Key features of the study:
Detailed Segmentation:
Table of Contents
*Browse 30 market data tables and 22 figures on “Latin America Oncology Device Market”- Latin America forecast to 2030
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients